Company insight High-tech I
n the context of economic circularity and sustainability, BEA Technologies’ research is oriented towards the creation of innovative filtration solutions to promote operational efficiency, reduce energy consumption and limit waste.
filtration solutions
Now more than ever, promoting economic circularity is key – regardless of the industry domain. Italian company BEA Technologies, one of the European leaders in filtration technologies, is committed to developing innovative products for challenging new applications.
president of BEA Technologies, who considers research and development as the key to success. “Our goal is to become the European reference leader in providing innovative filtration products for this sector; our efforts are dedicated to
“Our efforts are dedicated to consolidating our position as a significant global player, without losing sight of the need for a radical renewal of our economic model, aiming at circularity.”
In particular, in the field of filtration of critical products for the pharmaceutical sector, BEA Technologies has created MAGNEXFLO – an innovative, green solution that is suitable for solving a wide range of filtration problems. This system is highly versatile and can be customised to meet even the most specific needs. “We are currently studying green products, specific for pharmaceutical applications,” says Roberto Bea,
consolidating our position as a significant player, without losing sight of the need for a radical renewal of our economic model, aiming at circularity.”
New challenges to overcome The purification of gels for pharmaceutical use and liquids with a
viscosity higher than that of aqueous solutions represents a problem in drug production systems and filling glass containers, where low-flow speeds associated with sterile filtration of more viscous products are slowing down production processes – especially if depyrogenation and sterilisation filtration are required.
The purification of gels for use in the pharmaceutical, cosmetic and medical sectors is a challenge, especially if it is necessary to guarantee very low final endotoxin content. The gels are highly biocompatible and serve to coat the active ingredients, which allows a controlled release and increases the assimilable quantity of a specific drug. Recently, endotoxin-free purified gels have also become important in stabilising vaccines and other sensitive formulations, to reduce risks of secondary reactions for improved patient safety. These issues demand purpose-designed equipment – and BEA’s MAGNEXFLO, with its high capacity and automatic filtration technology, perfectly responds to this need. All BEA Technologies’ activities are regulated by the Quality Management Manual for design, production and distribution, and after-sales service phases. The Quality Management System is certified by an international body and recognised according to ISO 9001 and ISO 3834 standards since 1994. Thanks to this new line of automatic regenerable filters, the company supports the international commitment to sustainability and continues in the pursuit of its mission: to design filter elements and high-tech filtration systems capable of satisfying the industry’s evolving production needs, through the continuous improvement of processes and performances. ●
MAGNEXFLO by BEA Technologies is a fully automated and stand-alone filtration system for clarifying viscous gels and solutions.
42
www.bea-italy.com World Pharmaceutical Frontiers /
www.worldpharmaceuticals.net
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65
